Publication dates

All regions

Cancer Therapy Industry, October 2014 Market Research & Statistics

You might be interested in: drug, oncology, hospital, more »

1-10 of about 1 200 reports for Cancer Therapy

Clinical Trial Industry in the US

  • Nci Clinical Trials Portfolio Inventory Fy 2011
  • July 2013
    25 pages
  • Clinical Trial  

  • United States  

View report >

Pathology Description in the US

  • Cancer Statistics for African Americans, 2013
  • January 2013
    16 pages
  • Cancer  

  • United States  

    North America  

View report >

Pathology Description in the US

  • Facts Spring 2014
  • April 2014
    28 pages
  • Cancer  

  • United States  

    North America  

View report >

Pharmaceutical Industry in Germany

  • January 2013
    28 pages
  • Drug  

  • Germany  

    Europe  

    World  

View report >

Pathology Description in the US

  • Cancer Statistics, 2013
  • January 2013
    20 pages
  • Cancer  

  • United States  

    North America  

View report >

Pathology Description in the US

  • Cancer Statistics, 2013
  • January 2013
    20 pages
  • Cancer  

  • United States  

    North America  

View report >

Drug And Medication Market Share in the US and Canada

  • September 2014
    5 pages
  • Drug And Medica...  

    Drug  

  • United States  

    Canada  

View report >

Pathology Description in the US

  • Evaluation of Safety and Analgesic Consumption in Patients with ...
  • January 2013
    7 pages
  • Cancer  

    Prostate Cancer  

  • United States  

View report >

Pathology Description in the US

  • Lifesci Advisors
  • November 2013
    55 pages
  • Cancer  

    Oncology  

    Antibody  

  • United States  

View report >

Pathology Description in Europe

  • Background Paper 6.5 Cancer and Cancer Therapeutics
  • April 2013
    62 pages
  • Cancer  

  • Europe  

    World  

    United States  

View report >
8 reports for Cancer Therapy

Purchase Reports From Reputable Market Research Publishers
(From $ 250 - $ 4 995)

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

  • $ 2 495
  • Industry report
  • September 2014
  • by CHI Insight Pharma Reports

This report focuses on the rising potential for the newest and most promising of cancer treatments: cancer immunotherapy. Cancer immunotherapy was once just a dream in the minds of physicians, clinicians ...



ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.